Form D · Other Health Care

TRUELASTIN LABORATORIES, INC.

Chatham, NJ · CIK 0001756883

Offering snapshot reported Aug 5, 2022 · SEC filing

Reported sold
$1.28M
Offering amount: $6M
Investors reported
12
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 27, 2022
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 5, 2022Initial$1,280,000No comparison12SEC filing
Dec 4, 2020Initial$2,000,000No comparison12SEC filing
Oct 29, 2018Initial$250,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-455031

Source: Form D, filed Aug 5, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Steve Andrzejewski Director, Executive
Thomas M Ford Executive
Vladimir Grinyuk Director
Gurgen Melkumov Director
Mark Sheridan Executive
Vitaly Suslov Director
Yury Zhivilo Director
Bartholomew J. Zoni, Iii Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
43 Lake Road
Chatham, NJ, 07928